Friday, 22 November 2013

Global Prefilled Syringes Market Will Reach USD 4.98 Billion By 2019 : Transparency Market Research

Transparency Market Research is Published new Market Report “Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019," The global prefilled syringes market was valued at USD 2.09billion in 2012 and is expected to grow at a CAGR of 13.3% from 2013 to 2019, to reach an estimated value of USD 4.98billion in 2019.


Prefilled syringes are advanced drug delivery devices filled with single measured dose of high-end injectable drugs. Thesesyringes are gradually becoming the most preferred delivery devices for various categories of injectable drugs, mainly due to the advantages offered to drug manufacturers, healthcare providers and patients over conventional vial and ampoule packaging systems. To drug manufacturers, they are important because they reduce overfill to 4%-5% from 20% in vials, and thus, are preferred for dispensing therapeutic classes (mainly biologics) which are expensive. With respect to healthcare providers and patients, prefilled syringes help with factors such as ease of operation, low risk of contamination and accurate dosing.

Glass has been the most preferred material over decades for syringe manufacturing, owing to its properties such as non-reactive nature, robustness, transparency and tolerability against heat. Consequently, glass based prefilled syringes accounted for the larger share(more than 90%) of the total market in 2012, both by revenue as well as volume.Sincethe past few years, the industry is witnessing a shift towards the usage of plastic in place of glass in response to some significant disadvantages associated with glass, such as high risk of breakability and increased level of leachability from silicone layer in the presence of biologics. Under the influence of continued development in the area of polymer technology, the market for plastic based syringes is expected to grow at a CAGR more than double of that of glass syringes duringthe forecast period from 2013 to 2019. Nevertheless, glass syringes will still dominate the total global market for prefilled syringes in 2019, in terms of percent share by revenue as well as volume.

Boost in the use of biologics and other potent injectable drugs, technical advances in prefilled syringe manufacturing and packaging, rising demand for self-administration and increasing elderly population suffering from various chronic diseases that require frequent parenteral dosing are some major drivers anticipated totrigger market growth during the forecast period. On the other hand, burgeoning concerns regarding needlestick safety and prevention, rising manufacturing costs and issues with drug stability are some of the challenges likely to affect the growth of the global prefilled syringes market.

Geographically, Europe constituted the largest market share for prefilled syringes in 2012, owing to the high adoption rate of these delivery devices in the region. However, the North American market is predicted to grow at a higher CAGR (15%) than Europe during the forecast period to reach a value similar to that of the European market. Major drivers expected to contribute to this market growth include increasing awareness regarding benefits of prefilled syringes and presence of a large number of biopharmaceuticals under clinical development targeted for parenteral administration. In addition, the high growth economies of emerging nations such as India, China, Brazil, Russia and Mexico are attracting manufacturers to invest in these lucrative markets. Japan is a well-established market for prefilled syringes among Asian countries.

The market for prefilled syringes is oligopolistic in nature and is dominated by a few key players, namely, Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group. Other vendors operating in the market include Unilife Corporation, West Pharmaceutical Services, Inc., Baxter International, Inc. and Ypsomed Holding AG.

The global prefilled syringes market is segmented as follows:

Prefilled Syringes Market, by Segment
  • Glass Prefilled Syringes Market
    • By Revenue (USD Million)
    • By Volume (Million units)
    • Plastic Prefilled Syringes Market
    • By Revenue (USD Million)
    • By Volume (Million units)
Prefilled Syringes Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Blogs :





Hernia Repair Devices Market is Expected to Reach USD 5.9 Billion Globally in 2019


Transparency Market Research is Published new Market Report “Hernia Repair Devices Market
(Polymer and Prosthetic Mesh, Biologic Materials, Surgical Instruments and Endoscopy Equipments)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," The global hernia repair devices market was valued at USD 3,578.21 million in 2012 and is estimated to reach a market worth USD 5,936.43 million in 2019at a CAGR of 7.5% from 2013 to 2019.


Hernia is one of the major health concerns worldwide. Occurrence of hernia is characterized by the protrusion or bulging of internal organ or tissues through weak muscle areasand is classified on the basis of its anatomical location of occurrence. The different types of hernia include inguinal (inner groin), umbilical (belly button), hiatal (upper stomach), femoral (outer groin) and incisional hernia. Of these inguinal hernia is the most common type of hernia accounting for around 80% of the total hernia cases worldwide. This occurs most commonly in men majorly due to the observed weakness in this area. The exact cause of hernia is unknown but the most prominent risk factors which contribute in the development of hernia are old age and obesity. These factors feature weakened muscles and pressure in the abdomen. Other factors contributing towards development of hernia are poor nutrition, smoking, change in lifestyle habits, and family history.

Escalation in hernia prevalence directly influences the need and demand for hernia repair devices globally.Consistent rise in geriatric population, increasing adoption of tension free hernia repair procedures, rise in preference for technologically advanced biologic mesh and consistent elevation in obesity epidemic are some of the major factors positively impacting the growth and acceptance of hernia repair devices globally. However, inconsistent reimbursement policies coupled with high costs involved in the development of effective hernia repair devices are expected to hamper the growth and development of hernia repair devices market.

Hernia repair devices market can be segmented based on the type of product and equipment and procedure. The products and equipmentare further categorized into polymer and prosthetic mesh, biologic materials, surgical instruments and endoscopy equipment. Manufacturers are focusing on developing innovative and novel hernia repair products and equipment. The market for biologic materials is expected to grow faster compared to polymer or prosthetic mesh system as they render more advantages over the latter such as high flexibility, strength, less chances of rejection and infection. At present there has been increased adoption of biologic mesh and biologic allograft mesh systems which aid in fast recovery and negligible post-operative pain.
Continuous technological upgradation in developing endoscopes will further support growth and development of hernia repair devices. The rationale behind this is that these hi-tech endoscopes assure high reliability and accuracy of the surgical procedure with the minimum possibility of errors. Hence, with the perennial need for high performance oriented medical devices, the need and demand for effective hernia repair devices also increased.

Surgical procedure is the best option to deal with hernia as it provides long term results as compared to watchful waiting process for reverting hernia with the aid of certain medications. Tension repair and tension free repair procedures are the two main approaches employed for hernia repair. Tension free procedures are more advantageous than tension repair methods as they provide fast recovery and negligible post-operative pain. Currently, there has been an increased preference for tension free repair procedures such as laparoscopic tension free and tension free mesh technique majorly due to its minimal invasive nature followed by less susceptibility to infection compared to conventional incisional repair procedures. Owing to aforesaid factors, tension free repair procedures are anticipated to record a steady growth rate during the forecast period from 2013 to 2019.

At the regional level, North America was the largest market in 2012 for hernia repair devices market followed by the European Region. Asia-Pacific region is expected to grow at a highest CAGR of over 8% from 2013 to 2019. This is majorly due to large and expanding population base, increased participation of the respective governments in healthcare sector and rising disposable incomes of the population. In addition, high prevalence of hernia in low or middle income countries compared to high income countries due to undiagnosed and untreated hernia cases will further propel growth and development of hernia repair devices market.

The global hernia repair devices marketis segmented as follows:

Hernia Repair DevicesMarket, by Products and Equipments
  • Polymer and Prosthetic Mesh
  • Biologic Materials
  • Surgical Instruments
  • Endoscopy Equipments
Hernia Repair Devices Market, by Procedures
  • Open Tension Repair
  • Tension Free Repair
Hernia Repair Devices Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Monday, 21 October 2013

Atrial Fibrillation Market is Expected to Reach USD 14.8 Billion Globally in 2019: Transparency Market Research

Transparency Market Research is Published new Market Report “Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," . The global market for atrial fibrillation was valued at USD 6.1 billion in 2012 and it is expected to reach an estimated value of USD 14.8 billion in 2019, growing at a CAGR of 13.4% from 2013 to 2019.


Rising global base of geriatric population inducing an accelerated growth in the incidence rates of atrial fibrillation is one of the highest impact-rendering drivers for this market. In addition, favorable results exhibited by clinical trials promoting combined pharmacological therapy such as the HARMONY trial and rising prevalence of disorders causing atrial fibrillation such as hypertension and obesity will also serve the market as drivers. The future growth of this market will be ensured by the introduction of advanced treatment procedures such as hybrid ablation and the rising prevalence of atrial fibrillation in emerging Asian economies.

On account of the fact that pharmacological treatment procedures are more frequently administered to the patients suffering from atrial fibrillation and are a cheaper alternative to non-pharmacological procedures, pharmacological procedures held the majority of market share in 2012. With the introduction of new drugs such as Bristol Myer Squibb's NTC-801, Merck's Vernakalant, Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019.

The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45% in 2012. The introduction of new catheter ablation systems such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019.

The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it.
High prevalence of atrial fibrillation coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region.
Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc.

The global atrial fibrillation market is categorized into the following segments:
  • Atrial Fibrillation Market, by Treatment Types
    • Pharmacological Treatment
      • Anti-Arrhythmic Drugs
      • Anti-Coagulant Drugs
    • Non-Pharmacological Treatment
      • Catheter Ablation
        • Radiofrequency Based
        • Cryoablation Based
        • HIFU (High Intensity Focused Ultrasound) Based
        • Microwave Based
        • Laser Based
      • Maze Surgery
      • Electric Cardioversion
  • Atrial Fibrillation Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)


Blogs :





Tuesday, 15 October 2013

World Medical Tourism Market Will Climb Above USD 32.5 Billion in 2019 : Transparency Market Research


Transparency Market Research is Published new Market Report “Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” The global medical tourism market was valued at USD 10.5 billion in 2012 and is estimated to reach a market worth USD 32.5 billion in 2019 at a CAGR of 17.9% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/medical-tourism.html

Medical tourism is defined as an act of travel of patients from their home country to other destinations for availing medical services. Rise in healthcare costs in developed countries coupled with the availability of high quality medical services at a low cost in developing countries have given a boost to the medical tourism industry. These medical services range from elective procedures such as cosmetic surgeries to complicated surgeries such as cardiac, orthopedics, neurosurgery and others. Significant growth in this industry is due to economic developments in developing countries that in turn has led to the growth in the medical industry and quality of medical services.

Rise in the healthcare expenditure in developed countries coupled with in the growing elderly population has also contributed to the gowth of the medical tourism across the globe. Economic crisis in the U.S., increased the number of uninsured population, consequently further triggering the growth of this market. Recently, there are approximately 50 million uninsured Americans that are willing to travel abroad for affordable and quality medical care. Globalization and improved communication technology act as a catalyst to boost the growth of this industry.

The development of medical tourism industry is based on several factors such as reduced cost of procedures, long waiting time and high demand for cosmetic surgeries. Medical travel is not only witnessed for intricate procedures but is also expanding due to growing demand for cosmetic and dental procedures since these are usually not reimbursed under regular health insurance policies. Patients travelling abroad can save from 30% to 90% on a procedure, including their travel expenditures, as compared to the medical costs in their own countries. Long waiting time is another factor which has substantially boosted the growth of this industry. Patients based in Canada and U.K travel to low cost destinations for their treatments in order to avoid long waiting periods in their own countries and receive timely access to serious ailments.


Medical tourism industry is dominated by the Asian region that has captured the maximum share of the market. This region is highly competitive owing to the presence of technologically advanced medical specialties, less stringent government regulations and attractive locations. Thailand and India are recognized internationally for their high end medical services and receive patients from across the globe. Singapore is renowned for its healthcare infrastructure and receives patients primarily for complex medical procedures. Thailand, India and Singapore accounted for approximately 60% of the total revenue of the Asian region in 2012. The Latin American countries such as Brazil and Mexico attract maximum number of patients from the U.S owing to the geographic proximity and cultural similarities. Similarly, growth in Turkey is witnessed on account of growing demand of cosmetic surgeries.

Related & Recently Published Reports by Transparency Market Research

However, a paradigm shift in the market is seen owing to strong competition among the players of this industry. Malaysia is poised to have a significant growth in this market and is likely to emerge as a fastest growing country in terms of medical tourism with a CAGR of over 25% from 2013 to 2019. This advent in Malaysian medical tourism market is due to cost advantage over Thailand and Singapore. Moreover, rise in popularity of Malaysian region is attributed to many factors such as advanced healthcare infrastructure, highly skilled professionals, visa benefits and others. Additionally, robust government support for promotion of Malaysian medical tourism has propelled the growth in this nation.

Moreover, increase in the government initiatives and growing inclination of private sector hospitals towards medical tourism is further supplanting the growth of this market. Key healthcare providers in this industry include Apollo Hospitals Enterprise Ltd., Bumrumgrad International Hospital, Bangkok Medical Center, Prince Court Medical Center and others.

The Medical Tourism market is segmented as follows:

The global medical tourism market is segmented into the following categories:
  • Medical Tourism Market, by Geography
    • India
      • Overview
      • Cost Comparison of Procedures
      • SWOT Analysis
      • Government Support
      • India Inbound Medical Tourism (No. of patients)
      • India Medical Tourism: Top Revenue Contributing Country (%) (2012)
    • Thailand
    • Singapore
    • Malaysia
    • Mexico
    • Brazil
    • Turkey
    • South Korea
    • Taiwan
    • Prospective Countries
      • Costa Rica
      • Poland
      • Dubai
      • Philippines


Blogs :




Thursday, 19 September 2013

Infusion Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

An Infusion system is a device and any associated disposable used to deliver fluids, medication or nutrients in to the patient’s circulatory system. The most common route of administration of such products in patients is intravenous and is followed by subcutaneous, epidural or enteral route. Infusion systems are categorized into in five market segments namely, syringe pumps, infusion disposable sets, implantable infusion pumps, volumetric pumps and ambulatory infusion pumps. 


Infusion systems are basically designed to administer fluids which are otherwise impractically expensive or unreliable if done manually by nursing staff. The selection of infusion pump depends on criteria such as the required volume for infusion, long and short term accuracy and the speed of infusion. 

The major key factors contributing to the growth of this market is increasing demand for multi-functional infusion systems, advancement in infusion technologies, development in the reimbursement scenario and also increase in aging population and associated high prevalence of chronic pain. 

The major contribution for the global infusion systems market comes from North America followed by Europe. Their contribution is attributed to significant chronic pain in people and better reimbursement policies. The North America and Europe regions currently occupy more than half of the global market share for infusion pumps. The next big opportunity for the leading infusion systems manufacturers remains with the emerging economies of China, India, Brazil, Russia and South Africa, due to significantly large number of under-served patients. 

The global infusion systems market is highly fragmented in nature with prime market players enjoying approximately similar market shares. The major market players are Baxter International, Inc., CareFusion Corp., Fresenius Kabi AG, Hospira, Inc., ICU Medical, Inc., Medtronic, Inc., JMS Co. Ltd., Nipro Corp., and Terumo Corporation.

More reports on Medical Devices market: 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030

Friday, 13 September 2013

Electrodes for Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

The electrodes used in medical devices transfer the ionic current energy into electrical current in the body. These currents can be amplified and have proved to be helpful in diagnosing various diseases. Medical electrodes comprises of a lead, metal and electrode conducting paste. Medical electrodes proceed with quantification of internal ionic currents and results in diagnosis of various ocular, nervous, cardiac and muscular disorders. The device works through provision of an electrical contact between apparatus used to monitor activities and patient.  


The electrodes used in medical devices can be segmented as reusable disc, disposable, headbands and saline based electrodes. In addition, the electrodes can also be classified based on their applications such as ECG Electrodes, Blood Gas Electrodes, EEG/EMG/ENG Electrodes and Defibrillator Electrodes. Moreover, they can also be sub segmented as Fetal Scalp Electrodes, Electrosurgical Electrodes, TENS Electrodes, Pacemaker Electrodes, pH Electrodes, Nasopharyngeal Electrodes and Ion-selective Electrodes.

Rise in electrode applications through use of nanotechnology is augmenting the demand of electrode in various medical applications. Nanotechnology has supported the through miniaturization of these devices and making it portable.  In addition, the U.S. major government agencies such as National Eye Institute (NEI), National Science Foundation (NSF) and Department of Energy (DE) are supporting the R&D for this sector by increased government funding. The diseases treated with help of these devices include Parkinson’s disease, Alzheimer’s disease, sinus, body ache and others. Rise in incidences of these diseases would boost the demand of electrode medical devices worldwide. Moreover, the treatment through this device is of minimally invasive nature and has proved to propel the growth of this market substantially. In the U.S., the medical reimbursement policies include major medical electrodes which would also augment the growth of this market.

Some of the major players in electrodes for medical devices market include 3M Corporation, ZOLL Medical Corporation, Prosurg Inc., C.R Bard Inc., CONMED Corporation, Covidien and other significant players around the globe.

More reports on Medical Devices market:

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030


Thursday, 12 September 2013

Microfluidic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Microfluidics is a science that deals with the study of flow of liquid through the channels of micrometer size. It basically deals with the control and manipulation of fluids that is geometrically constrained to a sub-millimeter scale. Microfluidics field came into existence in 1990’s when microscale analytical chemistry technique and microelectronic technology began to be recognized. Since then microfluidics field has grown rapidly to control laboratory handling, processing and analytical techniques. Microfluidics also referred as lab-on-chip or micrototal analysis provides a wide range of applications in the areas of biological and chemical analysis. 


The miniaturization of bioanalytical techniques offers considerable advantages such as reduction of the size of the equipment and parallel operation for multiple analysis. Moreover, microlfuidic devices significantly reduce the sample volume and carry out the reaction, detection and separation quickly. Currently, microfluidic devices has been implemented in variety of biological applications that includes PCR amplification, DNA sequencing, amino acid and protein analysis, immunoassays and other areas. 

The microfluidic devices market is poised to show an impressive growth in the near future owing to advancements in proteomics and genomics field. The growth potential in this field has been driven due to acceleration in the fields of drug delivery, drug screening, biosensing, single cell or molecule analysis and point of care diagnostics. Moreover, through microfluidics entire bench top laboratory protocols can be integrated into a single chip that further supports the growth of  microfluidic devices market. 

Microfluidic market is a fast evolving market and has also been incorporated into the chemical and life sciences industry which are developing wide range of analytical and diagnostic applications. Microfluidics is further adding functionality to many of the MEMS devices. The technology facilitates chemical and biological reactions to be carried out and analyzed using typically nanoliter sample volume.  Additionally, microfluidics is also gaining momentum in the field of environmental monitoring, polymer synthesis, food monitoring, military applications and other areas. 

Microfluidic devices market is witnessing a significant competition among the vendors. The major players engaged in manufacturing of microfluidic devices are RainDance Technologies Inc., Fluidigm Corp., Agilent Technologies Inc., Dolomite Center Ltd. and other significant manufacturers.

More reports on Medical Devices market:

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About Us:

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:

CORPORATE OFFICE:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030